Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Massimo Pancione

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6589-5560; OpenAlex author ID A5074192479. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Altered centriolar cohesion by CEP250 and appendages impact outcome of patients with pancreatic cancer. Last author DOI 10.1016/j.pan.2024.06.010↗
  2. Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches. Co-author DOI 10.1155/2018/7530619↗
  3. Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. First author DOI 10.3748/wjg.v23.i32.5875↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guido Giordano · 3 shared papers, 2017–2024 · strength 0.33
  2. Paola Parente · 2 shared papers, 2018–2024 · strength 0.26
  3. Matteo Landriscina · 1 shared paper, 2024 · strength 0.18
  4. Evaristo Maiello · 1 shared paper, 2018 · strength 0.08
  5. Tiziana Pia Latiano · 1 shared paper, 2018 · strength 0.08
  6. Giuseppe Toffoli · 1 shared paper, 2017 · strength 0.07
  7. Mario Rosario D'Andrea · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.